相关实验视频

Updated: Jun 26, 2026

Enrichment of Native Lipoprotein Particles with microRNA and Subsequent Determination of Their Absolute/Relative microRNA Content and Their Cellular Transfer Rate

Enrichment of Native Lipoprotein Particles with microRNA and Subsequent Determination of Their Absolute/Relative microRNA Content and Their Cellular Transfer Rate

Published on: May 9, 2019

基于mRNA-脂质纳米颗粒的 pozitron发射断层学药业动力学:一项研究量化ApoE和巨的贡献

Kohta Mohri^1,2, Takayuki Miyazaki³, Shota Warashina^1,2

¹Laboratory for Molecular Delivery and Imaging Technology, RIKEN Center for Biosystems Dynamics Research, 6-7-3 minatojima-minamimachi, Chuo-ku, Kobe, Hyogo 650-0047, Japan.

ACS applied materials & interfaces

|August 4, 2025

概括

阳位子发射断层扫描 (PET) 成像揭示了信使RNA载脂纳米粒子 (mRNA-LNP) 在体内如何分布. 这项研究详细介绍了mRNA-LNP的药理动力学,强调了肝脏积累和蛋白质表达潜力.

科学领域:

药理学和制药科学药理学和制药科学
生物技术是生物技术.
医疗成像医学成像

背景情况:

带有信使RNA的脂质纳米粒子 (mRNA-LNP) 正在成为疫苗和治疗的关键平台.
了解mRNA-LNP的药理动力学对于其临床应用至关重要.
定子发射断层扫描 (PET) 为详细的药理动力学研究提供了高时间分辨率.

研究的目的:

开发一种准备用于PET成像的64Cu标记mRNA-LNP的方法.
在小鼠的静脉和肌肉内注射后,研究mRNA-LNP的体内药理学.
阐明mRNA-LNP积累,清除和蛋白质表达的机制.

主要方法:

64Cu标记的mRNA-LNP通过寡核酸杂交的开发.
在正常和功能缺陷的小鼠中进行PET的药理动力学研究.
使用整合图分析分析肝脏和清除的分析.
蛋白质表达水平与 luciferase 记者基因表达的比较.

主要成果:

静脉注射后mRNA-LNP表现出两步肝脏积累过程,涉及ApoE.
在静脉注射后5-10分钟内发生蛋白冠状形成.
通过ApoE吸收肝细胞对肝脏清除有显著的贡献.
肝细胞和抗原呈现细胞显示出高蛋白表达潜力.

结论:

PET成像为mRNA-LNP提供了详细的药理动力学数据.
ApoE在mRNA-LNP的肝脏吸收和清除中发挥着关键作用.
mRNA-LNP在向细胞中显示出治疗性蛋白质表达的显著潜力.

关键词:

64CuCu 64CuCu 是一个在 ApoEEE 中.集成图谱分析集成图谱分析脂质纳米颗粒的使用方法它们是mRNARNA.药物动力学药物动力学定子发射断层扫描 (PET).

更多相关视频

Preparation, Administration, and Assessment of In Vivo Tissue-Specific Cellular Uptake of Fluorescent Dye-Labeled Liposomes

Preparation, Administration, and Assessment of In Vivo Tissue-Specific Cellular Uptake of Fluorescent Dye-Labeled Liposomes

Published on: July 30, 2020

Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing

Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing

Published on: January 20, 2023

相关概念视频

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...